3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Colorectal Neoplasms
6
Stomach Neoplasms
3
Polyps
2
Neoplasms
2
Laryngeal Diseases
2
Hypopharyngeal Neoplasms
2
Carcinoma, Squamous Cell
2
Barrett Esophagus
2
Adenomatous Polyps
2
Adenoma
2
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Papilloma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Margins of Excision
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Inflammatory Bowel Diseases
1
Hypersensitivity
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Polyps
1
Interventions
Cisplatin
253
Radiotherapy
176
Cetuximab
145
pembrolizumab
120
Docetaxel
97
Fluorouracil
92
Carboplatin
80
Paclitaxel
77
Radiotherapy, Intensity-Modulated
69
Nivolumab
37
Radiation
30
Drug Therapy
30
Erlotinib Hydrochloride
26
Gemcitabine
25
Cyclophosphamide
22
Gefitinib
21
Surveys and Questionnaires
20
Standard of Care
20
Surgical Procedures, Operative
19
Pemetrexed
19
durvalumab
18
Magnetic Resonance Spectroscopy
17
Capecitabine
17
Radiosurgery
16
Celecoxib
16
atezolizumab
15
Filgrastim
15
Amifostine
15
130-nm albumin-bound paclitaxel
15
fludarabine
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Head and Neck Neoplasms
×
Narrow Band Imaging
×
Clear all
NCT01175499
2014-08-19
TNFE-NBI
University of California, San Francisco
Phase NA
Withdrawn